This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schetelig J, Kiani A, Schmitz M, Ehninger G, Bornhäuser M . T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation. Cancer Immunol Immunother 2005; 54: 1043–1058.
Luznik L, Fuchs EJ . High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res 2010; 47: 65–77.
Luznik L, O’Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, post-transplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641–650.
Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai HL, Bolaños-Meade J et al. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose post-transplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant 2010; 16: 482–489.
Mayumi H, Himeno K, Tokuda N, Nomoto K . Drug-induced tolerance to allografts in mice. VII. Optimal protocol and mechanism of cyclophosphamide-induced tolerance in an H-2 haplotype-identical strain combination. Transplant Proc 1986; 18: 363–369.
Nomoto K, Eto M, Yanaga K, Nishimura Y, Maeda T . Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A. J Immunol 1992; 149: 2668–2674.
Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097–2100.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Author contributions
MF performed the determination of KIR-L mismatching. ST, JG, CS, JR, AK, DS, UP, GRM, MW, UH, PB, JMM, NS, JMC, AK, NG, JS, GE, MH, JLDM and MB were responsible for clinical care and out-patient follow-up. CT performed chimerism analyses. ST, JG, CS and MB wrote the paper and we have read and approved the final version of the manuscript.
Rights and permissions
About this article
Cite this article
Tuve, S., Gayoso, J., Scheid, C. et al. Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy. Leukemia 25, 880–883 (2011). https://doi.org/10.1038/leu.2011.11
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.11
This article is cited by
-
Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
Bone Marrow Transplantation (2019)
-
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas
Bone Marrow Transplantation (2014)
-
Haploidentical transplantation in patients with acquired aplastic anemia
Bone Marrow Transplantation (2013)